By: Stephanie Soucheray
If the third vaccine dose was administered 16 weeks or less before infection, healthcare providers had lower odds of reporting respiratory symptoms (aOR, 0.69; 95% CI, 0.46 to 0.99), psychiatric symptoms (aOR, 0.68; 95% CI, 0.47 to 0.99), or any symptom (aOR, 0.68; 95% CI, 0.53 to 0.87) than those who received the dose more than 16 weeks earlier.